Cancer drug

Ended Awarded

Contract number
36C25621F0071
Awardee
Awarding agency
Obligated
$71,170

Award facts

Contract value 100% obligated
$71,169.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cary, NC 27513, USA

Award details come from SAM.gov/FPDS.

About this award

Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $71,169.70 firm fixed price delivery order against the Pharmaceuticals and Drugs multiple-award schedule held by its parent company, GSA Schedule FSS-61-IB. The contract calls for Genzyme to provide cancer drugs to support programs run by the Department of Veterans Affairs' Veterans Health Administration Veterans Integrated Service Network 16 located in Cary, North Carolina. No set-aside designation was applied to this order. Genzyme will fulfill the contract through place of performance in Cary.

Quick answers

Who was awarded contract 36C25621F0071?

36C25621F0071 was awarded to Genzyme Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 20, 2020.

How much is contract 36C25621F0071 worth?

The government has obligated $71,170 on 36C25621F0071.

Is contract 36C25621F0071 an order under another contract?

Yes. 36C25621F0071 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25621F0071 competed?

The extent of competition for 36C25621F0071 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award